Skip to main content

Advertisement

SpringerLink
Log in

Fecal microbiota transplantation for management of Clostridium difficile infection

  • Review Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

The widespread use of antibiotics has led Clostridium difficile infection (CDI) to become a common problem with pronounced medical and economic effects. The recurrence of CDI after treatment with standard antibiotics is becoming more common with the emergence of more resistant strains of C. difficile. As CDI is an antibiotic-associated disease, further treatment with antibiotic is best avoided. As the gut flora is severely disturbed in CDI, approaches that restore the gut microbiota may become good alternative modes of CDI therapies. Fecal microbiota transplantation (FMT) is the procedure of transplantation of fecal bacteria from a healthy donor individual into a patient for restoration of the normal colonic flora. Thus, FMT helps in the eradication of C. difficile and resolution of clinical symptoms such as diarrhea, cramping, and urgency. Though this approach to treatment is not new, presently, it has become an alternative and promising way of combating infections. The procedure is not in regular use because of the time required to identify a suitable donor, the risk of introducing opportunistic pathogens, and a general patient aversion to the transplant. However, FMT is gaining popularity because of its success rate as a panacea for recurrent attacks of CDI and is being increasingly used in clinical practice. This review describes the rationale, the indications, the results, the techniques, the potential donors, the benefits as well as the complications of fecal microbiota instillation to CDI patients in order to restore the normal gut flora.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe. 2009;15:285–9.

  2. van Nood E, Speelman P, Kuijper EJ, Keller JJ. Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill. 2009;14. pii:19316.

  3. Kelly CP. Fecal microbiota transplantation—an old therapy comes of age. N Engl J Med. 2013;368:474–5.

    Article  CAS  PubMed  Google Scholar 

  4. Sanders WE, Sanders C. Modification of normal flora by antibiotics: Effects on individuals and the environment. In: Root RK, Sande MA, (eds). New Dimensions in Antimicrobial Therapy: Contemporary Issues in Infectious Diseases. New York: Churchill Livingstone; 1984. pp. 217–41.

  5. Grehan MJ, Borody TJ, Leis SM, et al. Durable alternation of the colonic microbiota by administration of donor fecal flora. J Clin Gastroenterol. 2010;44:551–61.

    Article  PubMed  Google Scholar 

  6. Buffie CG, Jarchum I, Equinda M, et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun. 2012;80:62–73.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67:742–8.

    Article  CAS  PubMed  Google Scholar 

  8. Lawley TD, Clare S, Deakin LJ, et al. Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol. 2010;76:6895–900.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Deakin LJ, Clare S, Fagan RP, et al. Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun. 2012;80:2704–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Lawley TD, Clare S, Walker AW, et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun. 2009;77:3661–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Rohlke F, Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Ther Adv Gastroenterol. 2012;5:403–20.

    Article  Google Scholar 

  12. Smits LP, Bouter KEC, De Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013;145:946–53.

    Article  PubMed  Google Scholar 

  13. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011;9:88–96.

    Article  PubMed  Google Scholar 

  14. Rembacken BJ, Snelling M, Hawkey PM, Chalmers DM, Axon A. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999;354:635–9.

    Article  CAS  PubMed  Google Scholar 

  15. Lanzini A, Lanzaroto F, Villanacci V, et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther. 2009;29:1299–308.

    Article  CAS  PubMed  Google Scholar 

  16. Brandt L, Aroniadis O, Mellow M, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079–87.

    Article  PubMed  Google Scholar 

  17. Ananthaswamy A. Faecal transplant eases symptoms of Parkinson’s. New Sci. 2011;209:8–9.

    Google Scholar 

  18. Borody TJ, Warren EF, Leis SM, et al. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol. 2004;38:475–83.

    Article  PubMed  Google Scholar 

  19. Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044–9.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854–9.

    CAS  PubMed  Google Scholar 

  21. Bowden TA, Mansberger AR, Lykins LE. Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg. 1981;47:178–83.

    PubMed  Google Scholar 

  22. Schwan A, Sjölin S, Trottestam U, et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis. 1984;16:211–5.

    Article  CAS  PubMed  Google Scholar 

  23. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet. 1989;1:1156–80.

    Article  CAS  PubMed  Google Scholar 

  24. Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol. 2000;95:3283–5.

    CAS  PubMed  Google Scholar 

  25. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580–5.

    Article  PubMed  Google Scholar 

  26. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913–8.

    Article  CAS  PubMed  Google Scholar 

  27. Chang JY, Antopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008;197:435–8.

    Article  PubMed  Google Scholar 

  28. Khoruts A, Dicksved J, Jansson JK, et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2010;44:354–60.

    PubMed  Google Scholar 

  29. You DM, Franzos MA, Holman RP. Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann Intern Med. 2008;148:632–3.

    Article  PubMed  Google Scholar 

  30. Yoon S, Brandt LJ. Treatment of refractory/recurrent C. difficile-associated disease (CDI) by donated stool transplanted via colonoscopy: a case series of twelve patients. J Clin Gastroenterol. 2010;44:562–6.

    Article  PubMed  Google Scholar 

  31. Rohlke F, Surawicz CM, Stollman NH. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol. 2010;44:567–70.

    Article  PubMed  Google Scholar 

  32. Kaur S, Vaishnavi C, Ray R, Kochhar R, Prasad KK. Effect of biotherapeutics on cyclosporine-induced Clostridium difficile infection in mice. J Gastroenterol Hepatol. 2010;25:1–7.

    Article  Google Scholar 

  33. Borody T, Wettstein A, Leis S, Hills L, Campbell J, Torres M. Clostridium difficile complicating inflammatory bowel diseases: pre- and post-treatment findings. Gastroenterology. 2008;134 4 Suppl 1:A–361.

    Google Scholar 

  34. Anderson JL, Edney RJ, Whelan K. Systematic review: fecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:503–16.

    Article  CAS  PubMed  Google Scholar 

  35. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53:994–1002.

    Article  PubMed  Google Scholar 

  36. Russell G, Kaplan J, Ferraro M, Michelow I. Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics. 2010;126:e239–42.

    Google Scholar 

  37. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407–15.

    Article  PubMed  Google Scholar 

  38. Lund-Tonnesen S, Berstad A, Schreiner A, et al. Clostridium difficile-associated diarrhea treated with homologous feces. Tidsskr Nor Laegeforen. 1998;118:1027–30.

    CAS  PubMed  Google Scholar 

  39. Hamilton M, Weingarden A, Sadowsky M, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:761–7.

    Article  PubMed  Google Scholar 

  40. Wettstein A, Borody T, Leis S, Chongan J, Torres M, Hills L. Faecal bacteriotherapy—an effective treatment for relapsing symptomatic Clostridium difficile infection. Abstract WED-G-67. In: 15th Gut. United European Gastroenterology Week. United European Gastroenterology Federation, France, 2007:39 Suppl 1.

  41. Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol. 2010;8:471–3.

    Article  PubMed  Google Scholar 

  42. Kassam Z, Hundal R, Marshall J, Lee C. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med. 2012;172:191–3.

    Article  PubMed  Google Scholar 

  43. Paterson D, Iredell J, Whitby M. Putting back the bugs: bacterial treatment relieves chronic diarrhoea. Med J Aust. 1994;160:232–3.

    CAS  PubMed  Google Scholar 

  44. Louie T. Home-based fecal flora infusion to arrest multiply-recurrent Clostridium difficile infection (CDI). In: Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington DC) Arlington, VA: Infectious Disease Society of America, 2008.

  45. MacConnachie A, Fox R, Kennedy D, Seaton R. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM. 2009;102:781–4.

    Article  CAS  PubMed  Google Scholar 

  46. Rubin T, Gessert C, Aas J. Stool transplantation for older patients with Clostridium difficile infection. J Am Geriatr Soc. 2009;57:2386.

    Article  PubMed  Google Scholar 

  47. Duplessis C, You D, Johnson M, Speziale A. Efficacious outcome employing fecal bacteriotherapy in severe Crohn’s colitis complicated by refractory Clostridium difficile infection. Infection. 2012;40:469–72.

    Article  CAS  PubMed  Google Scholar 

  48. Nieuwdorp M, van Nood E, van Speelman P, et al. Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces. Ned Tijdschr Geneeskd. 2008;152:1927–32.

    CAS  PubMed  Google Scholar 

  49. Garborg K, Waagsbo B, Stallemo A, Matre J, Sundoy A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis. 2010;42:857–61.

    Article  PubMed  Google Scholar 

  50. Gustafsson A, Berstad A, Lund-Tonnesen S, Midtvedt T, Norin E. The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol. 1999;34:580–6.

    Article  CAS  PubMed  Google Scholar 

  51. Kelly C, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol. 2012;46:145–9.

    Article  PubMed  Google Scholar 

  52. Ho N, Prasad V. Clostridium difficile diarrhea and fecal transplantation. J Clin Gastroenterol. 2011;45:742–3.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

CV does not have any conflict of interest to declare.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Chetana Vaishnavi

Authors
  1. Chetana Vaishnavi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chetana Vaishnavi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaishnavi, C. Fecal microbiota transplantation for management of Clostridium difficile infection. Indian J Gastroenterol 33, 301–307 (2014). https://doi.org/10.1007/s12664-014-0459-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-014-0459-x

Keywords

Search

Navigation